Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2019-11-13 | 2020-03-28 | 98572 |
TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-11-13 | 2019-11-18 | 98575 |
ALYSENA 21 | 20MCG 100MCG | TABLET | Resolved | 2019-11-20 | 2019-12-09 | 99287 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2019-11-20 | 2019-12-19 | 99290 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Resolved | 2019-11-20 | 2019-12-04 | 99295 |
APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99299 |
APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99304 |
APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2019-11-20 | 2020-04-07 | 99311 |
APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-11-20 | 2019-11-25 | 99320 |
APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-11-27 | 2020-03-13 | 99786 |
APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-11-27 | 2020-03-13 | 99789 |
APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-11-27 | 2020-04-06 | 99795 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2019-12-05 | 2020-01-07 | 100200 |
APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2019-12-05 | 2019-12-16 | 100203 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-12-05 | 2019-12-16 | 100255 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-12-05 | 2020-01-22 | 100262 |
APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2019-12-05 | 2020-02-18 | 100265 |
APO-DEXAMETHASONE | 0.5MG | TABLET | Resolved | 2019-12-05 | 2020-09-21 | 100271 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |